Vistagen Therapeutics (VTGN) 10-K Changes Lead 15 June 2026 Filing Roundup

Vistagen Therapeutics (VTGN) led the biggest 10-K filing change among 7 companies that filed annual reports on 15 June 2026, each compared against its…

Desk:
SEC What Changed — 15 June 2026 10-K filing snapshot
VTGN-66.50%
CGC-22.02%
GWAV-82.01%
AIOT-12.33%
CRDO+217.89%

Seven companies met our criteria from the eight 10-K annual reports filed with the SEC on 15 June 2026. To qualify, a company must have filed an annual 10-K report on the target date and have a prior-year 10-K available for a direct year-over-year comparison. A prior-year filing was not available for Quantumsphere Acquisition Corp, so it is excluded from the ranking.

SEC What Changed Methodology

Each company is scored on how similar its current annual filing text is to the prior year. Scores run from 0 to 1 — a score of 1 means the language is essentially unchanged; a lower score means more has changed. We flag three sections that carry the most disclosure signal: Business, Risk Factors, and MD&A. Recent research suggests that lower scores indicate that a company has made significant changes to their filings, these changes are often buried in the filings. If a company was to report positive news, they would likely do so in the form of a press release or statement on their website. The large changers have often underperformed in the market, while the stable-language filers have earned positive abnormal returns.

Key Takeaways

  • Vistagen Therapeutics, Inc. (High) — Vistagen is now signaling that cash preservation and successful PALISADE execution are critical, with going concern and Nasdaq risks making the stock more dependent on near-term clinical and financing milestones.
  • Canopy Growth Corp (High) — The key issue is the restatement: Canopy must now rebuild investor confidence after admitting prior financials were wrong because warrants were booked in the wrong accounting bucket.
  • PILLARSTONE CAPITAL REIT (High) — The key change is that Pillarstone now plainly frames the investment around Chapter 11 outcomes, making equity recovery highly uncertain despite the Whitestone settlement.
  • Powerfleet, Inc. (High) — Powerfleet is telling investors that the post-acquisition integration story is still risky and that profitability remains the key issue to watch.
  • Greenwave Technology Solutions, Inc. (Medium) — Greenwave is now clearly a pure-play scrap recycler with a logistics expansion plan, but its stock-price compliance risk remains elevated.
  • Alternus Clean Energy, Inc. (Medium) — Alternus is betting its future on microgrids and EverOn, but the strategy is being launched under heavy legal and liquidity stress.
  • Credo Technology Group Holding Ltd (Medium) — Credo is flagging a more uncertain macro and geopolitical backdrop, which raises the risk that demand and execution could be less predictable.

Ranking Table

RankCompanyCIKFull Filing SimilarityBusiness SimilarityRisk Factors SimilarityMD&A SimilarityMost Changed SectionAssessment
1Vistagen Therapeutics, Inc.14116850.6540.9970.999n/aBusinesshigh
2Canopy Growth Corp17379270.980.7820.9980.979Businesshigh
3PILLARSTONE CAPITAL REIT9289530.9860.9960.990.963MD&Ahigh
4Powerfleet, Inc.17741700.9950.9930.9770.989Risk Factorshigh
5Greenwave Technology Solutions, Inc.15891490.990.9120.9930.996Businessmedium
6Alternus Clean Energy, Inc.18839840.9620.9930.992n/aRisk Factorsmedium
7Credo Technology Group Holding Ltd18077940.9920.990.9990.999Businessmedium

Vistagen Therapeutics, Inc.

Rank1
Lowest similarity sectionBusiness
Assessmenthigh
SEC filings2026 10-K HTML/iXBRL (SEC page, raw text) | 2025 10-K HTML/iXBRL (SEC page, raw text)

Vistagen’s filing shifts from a broad pipeline narrative to a more cash-conscious story centered on fasedienol and the PALISADE program. The company also disclosed a 20% workforce reduction and added explicit going concern and Nasdaq delisting risks, which points to tighter financing conditions and a stronger need for clinical execution. The pipeline language was also refreshed, including a new named program for menopausal hot flashes.

Main Changes

  • The business overview now says Vistagen is focused on developing and potentially commercializing medicines for social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia, replacing the prior broader phrasing about a "new class" of pherines and "long term value" language.
  • The pipeline was updated to name refisolone for menopausal vasomotor symptoms, while the prior overview highlighted PH80 for hot flashes and premenstrual dysphoric disorder; the new text also removes the earlier emphasis on PH80 and PH15/PH284 exploratory study descriptions.
  • The company added that on March 5, 2026 the Board approved a reduction of approximately 20% of the workforce to support "disciplined cash management" and prioritize execution of the PALISADE Program, and later granted retention stock options to remaining employees.
  • Risk factors now explicitly state the company requires substantial additional financing to execute its long-term plan and "continue to operate as a going concern," and add a new Nasdaq risk that failure to regain compliance with continued listing requirements could lead to delisting and hurt access to capital.

Watch Items

  • The going concern disclosure signals tighter liquidity and raises the stakes for near-term financing, especially if PALISADE data do not support a regulatory path.
  • The 20% workforce reduction suggests management is preserving cash and concentrating resources on fasedienol, which can help runway but also indicates operating pressure.
  • The new Nasdaq compliance risk matters because a delisting would likely reduce trading liquidity and make future capital raises more difficult.

Important Filing Changes

2025 filing excerpt – Business

Fasedienol has the potential to be the first FDA-approved acute treatment for SAD and provide significant advantages relative to the current standard of care. We have also reported positive results from an exploratory Phase 2A clinical trial for each of our next most advanced pherine product candidates, itruvone for treatment of major depressive disorder, and PH80 for both vasomotor symptoms (hot flashes) due to menopause and premenstrual dysphoric disorder, as well as a pilot Phase 2A study of PH15 for improvement of psychomotor impairment due to mental fatigue and an exploratory Phase 2A study of PH284 for treatment of cancer cachexia. See “Our Neuroscience Product Candidates” below.

2026 filing excerpt – Business

Business Overview We are a late clinical-stage therapeutics company focused on developing and potentially commercializing new medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. Each of the five clinical-stage intranasal pherine product candidates in our neuroscience pipeline has a novel neurocircuitry-focused proposed mechanism of action (MOA) and at least one positive clinical study in its targeted patient population.

2025 filing excerpt – Business

Business Overview We are a late clinical-stage biopharmaceutical company leveraging a deep understanding of nose-to-brain neurocircuitry to develop and commercialize a new class of non-systemic intranasal product candidates called pherines. Our broad and diverse neuroscience pipeline currently consists of five clinical-stage pherine product candidates, each with a novel mechanism of action (MOA) and positive clinical data in their targeted indication(s). Pherines specifically and selectively bind to peripheral receptors in human nasal chemosensory neurons, and are designed to rapidly activate nose-to-brain neurocircuits believed to regulate brain areas without requiring systemic absorption or uptake into the brain to achieve desired therapeutic benefits.

2026 filing excerpt – Business

Business Overview We are a late clinical-stage therapeutics company focused on developing and potentially commercializing new medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. Each of the five clinical-stage intranasal pherine product candidates in our neuroscience pipeline has a novel neurocircuitry-focused proposed mechanism of action (MOA) and at least one positive clinical study in its targeted patient population. Leveraging our deep understanding of nose-to-brain neurocircuitry, we have designed our intranasal pherine product candidates are designed to rapidly, specifically and selectively bind to peripheral receptors in human nasal chemosensory neurons and rapidly activate neurocircuits believed to regulate brain areas, without requiring systemic absorption or uptake into the brain to achieve desired therapeutic benefits.

Canopy Growth Corp

Rank2
Lowest similarity sectionBusiness
Assessmenthigh
SEC filings2026 10-K HTML/iXBRL (SEC page, raw text) | 2025 10-K HTML/iXBRL (SEC page, raw text)

Canopy Growth’s new filing is dominated by a material restatement tied to how it accounted for certain U.S.-dollar warrants. Management says the error was technical, but it forced revisions to prior annual and quarterly financials and caused earlier reports to be withdrawn from reliance. The business section also adopts a more mission-focused tone, emphasizing improving lives through cannabis rather than simply describing the company’s market position.

Main Changes

  • The company added an explanatory note saying this is a "Comprehensive Form 10-K" covering fiscal 2026, 2025 and 2024, and that it includes restated prior annual and quarterly financial statements.
  • Canopy says the restatement was triggered by "non-cash technical errors" in accounting for U.S.-dollar-denominated share-settled warrants, which should have been recorded as liabilities rather than equity instruments.
  • The filing states the 2025 and 2024 10-Ks and multiple quarterly reports "should no longer be relied upon," and that the affected balance sheets, loss statements, shareholders’ equity and cash flow statements were revised.
  • The Business overview was rewritten with more mission-led language, shifting from a broad "world-leading cannabis company" description to "We are here to better lives through cannabis" and emphasizing patient, veteran and consumer outcomes.

Watch Items

  • A restatement that reaches prior annual and quarterly periods raises credibility and controls questions, even if management calls the issue technical and non-cash.
  • Reclassifying warrants as liabilities can increase earnings volatility because fair value changes now flow through the income statement.
  • The more purpose-driven business framing suggests management is sharpening its brand and market positioning, which may matter for product strategy and investor messaging.

Important Filing Changes

2025 filing excerpt – Business

Exhibits and Financial Statement Schedules 143 Item 16. Form 10-K Summary 148 SIGNATURES 149 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND SCHEDULES F- 1 Unless otherwise noted or the context indicates otherwise, references in this Annual Report on Form 10-K (“Form 10-K”) to the “Company,” “Canopy Growth,” “we,” “us” and “our” refer to Canopy Growth Corporation, its direct and indirect wholly-owned subsidiaries and investments accounted for by the equity method; the term “cannabis” means the plant of any species or subspecies of genus Cannabis and any part of that plant, including all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers; and the term “hemp” has the meaning given to such term in the U.S. Agricultural Improvement Act of 2018 (the “2018 Farm Bill”), including hemp-derived cannabidiol (“CBD”).

2026 filing excerpt – Business

Exhibits and Financial Statement Schedules 225 Item 16. Form 10-K Summary 229 SIGNATURES 230 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND SCHEDULES F- 1 Unless otherwise noted or the context indicates otherwise, references in this Comprehensive Form 10-K (as defined below) to the “Company,” “Canopy Growth,” “we,” “us” and “our” refer to Canopy Growth Corporation and its direct and indirect wholly-owned subsidiaries and investments accounted for by the equity method; the term “cannabis” means the plant of any species or subspecies of genus Cannabis and any part of that plant, including all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers; and the term “hemp” has the meaning given to such term in the U.S. Agricultural Improvement Act of 2018 (the “2018 Farm Bill”), including hemp-derived cannabidiol (“CBD”).

2025 filing excerpt – Business

Agricultural Improvement Act of 2018 (the “2018 Farm Bill”), including hemp-derived cannabidiol (“CBD”). This Form 10-K contains references to our trademarks and trade names and to trademarks and trade names belonging to other entities. Solely for convenience, trademarks and trade names referred to in this report may appear without the ® or ™ symbols, but such references are not intended to indicate, in any way, that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto.

2026 filing excerpt – Business

Agricultural Improvement Act of 2018 (the “2018 Farm Bill”), including hemp-derived cannabidiol (“CBD”). This Comprehensive Form 10-K contains references to our trademarks and trade names and to trademarks and trade names belonging to other entities. Solely for convenience, trademarks and trade names referred to in this report may appear without the ® or ™ symbols, but such references are not intended to indicate, in any way, that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto.

2025 filing excerpt – MD&A

Management’s Discussion and Analysis of Financial Condition and Results of Operations. Introduction This Management’s Discussion and Analysis of our financial condition and results of operations (“MD&A”), which should be read in conjunction with our consolidated financial statements and the notes thereto included in Item 8 of this Form 10-K (the “Financial Statements”), provides additional information on our business, current developments, financial condition, cash flows and results of operations. It is organized as follows: • Part 1 – Business Overview.

2026 filing excerpt – MD&A

Management’s Discussion and Analysis of Financial Condition and Results of Operations. Introduction This Management’s Discussion and Analysis of our financial condition and results of operations (“ MD&A”), which should be read in conjunction with our consolidated financial statements and the notes thereto included in Item 8 of this Comprehensive Form 10-K (the “Financial Statements”), provides additional information on our business, current developments, financial condition, cash flows and results of operations. The discussion in this section has been impacted by the restatement described in the Explanatory Note at the beginning of this Comprehensive Form 10-K and in Note 2 and Note 35 of the consolidated financial statements of this Comprehensive Form 10-K.

PILLARSTONE CAPITAL REIT

Rank3
Lowest similarity sectionMD&A
Assessmenthigh
SEC filings2026 10-K HTML/iXBRL (SEC page, raw text) | 2025 10-K HTML/iXBRL (SEC page, raw text)

Pillarstone’s new filing is much more explicit about its bankruptcy status and the possibility that the company may liquidate rather than continue as a going concern. It also discloses a settlement with Whitestone on most claims, while leaving the Uptown Tower bankruptcy dispute unresolved. The added cybersecurity section is more of a governance update than a business driver.

Main Changes

  • The MD&A now explicitly says the company and its subsidiaries are in Chapter 11, with forward-looking risks tied to "plans of liquidation and reorganization" and the possibility of emerging from bankruptcy.
  • The filing adds that the company reached a settlement with Whitestone REIT, Whitestone REIT Operating Partnership, L.P. and Whitestone TRS, Inc., with the bankruptcy court retaining jurisdiction to enforce it.
  • The new MD&A also says claims in the Whitestone Uptown Tower, LLC bankruptcy case were not settled and remain outstanding.
  • A new cybersecurity section was added stating the board oversees cyber risk, the company uses third-party consultants, and cyber threats have not materially affected the business since the Whitestone management agreements ended.

Watch Items

  • Chapter 11 and liquidation language signals a materially higher risk that equity holders could be wiped out if creditors are not paid in full.
  • The Whitestone settlement may reduce litigation overhang, but unresolved Uptown Tower claims leave some legal and financial uncertainty in place.
  • The added cybersecurity disclosure suggests management is formalizing controls, but the company still lacks deep in-house expertise.

Important Filing Changes

2025 filing excerpt – MD&A

The bankruptcy cases were consolidated into the jointly administered cases styled In re: Whitestone Industrial-Office, LLC, et. al. , Case No. 24-30653-mvl-11, in the United States Bankruptcy Court for the Northern District of Texas, Dallas Division, the same court as the Whitestone Uptown Tower, LLC bankruptcy case described under “—Uptown Tower” below. The joint plan of liquidation in the bankruptcy case providing for the sale of the Real Estate Assets other than Uptown Tower and treatment of claims was confirmed in November 2024.

2026 filing excerpt – MD&A

Management’s Discussion and Analysis of Financial Condition and Results of Operations. On December 1, 2023, Whitestone Uptown Tower, LLC, an indirect subsidiary of Pillarstone Capital REIT (the “ Company, ” “ Pillarstone, ” “ we, ” “ our, ” or “ us ” ), filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Northern District of Texas in the case styled In re: Whitestone Uptown Tower, LLC a/a/ Pillarstone Capital REIT Operating Partnership, Case No. 23-32832-mvl-11, in the United States Bankruptcy Court for the Northern District of Texas, Dallas Division.

2025 filing excerpt – MD&A

The bankruptcy cases were consolidated into the jointly administered cases styled In re: Whitestone Industrial-Office, LLC, et. al. , Case No. 24-30653-mvl-11, in the United States Bankruptcy Court for the Northern District of Texas, Dallas Division, the same court as the Whitestone Uptown Tower, LLC bankruptcy case described under “—Uptown Tower” below. The joint plan of liquidation in the bankruptcy case providing for the sale of the Real Estate Assets other than Uptown Tower and treatment of claims was confirmed in November 2024.

2026 filing excerpt – MD&A

On December 1, 2023, Whitestone Uptown Tower, LLC, an indirect subsidiary of Pillarstone Capital REIT (the “ Company, ” “ Pillarstone, ” “ we, ” “ our, ” or “ us ” ), filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Northern District of Texas in the case styled In re: Whitestone Uptown Tower, LLC a/a/ Pillarstone Capital REIT Operating Partnership, Case No. 23-32832-mvl-11, in the United States Bankruptcy Court for the Northern District of Texas, Dallas Division. GAAP, we deconsolidated Whitestone Uptown Tower, LLC from our consolidated financial statements effective December 1, 2023, the date of its bankruptcy filing.

2025 filing excerpt – Risk Factors

Noncompliance could result in the imposition of fines by the federal government or the award of damages to private litigants. If, under the Americans with Disabilities Act, we are required to make substantial alterations and capital expenditures in one or more of our properties, including the removal of access barriers, it could adversely affect our financial condition and results of operations. Our properties are subject to various federal, state and local regulatory requirements, such as state and local fire and life safety requirements.

2026 filing excerpt – Risk Factors

Compliance or failure to comply with the Americans with Disabilities Act or other safety regulations and requirements could result in substantial costs . The Americans with Disabilities Act generally requires that certain buildings, including office buildings, residential buildings and hotels, be made accessible to disabled persons.

Powerfleet, Inc.

Rank4
Lowest similarity sectionRisk Factors
Assessmenthigh
SEC filings2026 10-K HTML/iXBRL (SEC page, raw text) | 2025 10-K HTML/iXBRL (SEC page, raw text)

Powerfleet’s risk factors were materially expanded to emphasize integration, transformation and profitability risk after its acquisition-heavy period. Management now explicitly warns that it may not realize the expected benefits of those deals and that ongoing losses and accumulated deficits could hurt the stock. The filing also broadens exposure to inflation, rates, FX, tariffs, sanctions and supplier dependence.

Main Changes

  • New risk language says the company "may not fully realize the anticipated benefits" of its acquisitions and "ongoing business transformation initiatives," and that these efforts could hurt business, financial condition and results of operations.
  • A new risk was added that "significant losses, accumulated deficits and an inability to achieve or sustain profitability" may adversely affect financial condition and the stock price.
  • The macro risk disclosure was expanded to include "inflation, interest rate increases, foreign exchange instability, geopolitical conflicts, sanctions, export controls and the potential imposition of tariffs."
  • Supply-chain risk was sharpened to mention "performance issues or failures by subcontractors" and reliance on a "limited number of suppliers for critical components and services."

Watch Items

  • The added profitability warning suggests management sees execution risk around turning recent acquisitions and integration work into durable earnings.
  • Broader macro and supply-chain risks point to more pressure from FX, geopolitics and vendor concentration, which can hit margins and delivery timing.
  • The new language around stock price impact signals the company is acknowledging that losses and deficits could weigh on investor sentiment.

Important Filing Changes

2025 filing excerpt – Risk Factors

Properties Our corporate headquarters are located in Woodcliff Lake, New Jersey. We also have domestic offices in Florida and Texas. Our New Jersey offices measure approximately 1,000 square feet and are leased space.

2026 filing excerpt – Risk Factors

Properties Our corporate headquarters are located in Woodcliff Lake, New Jersey. We also have domestic offices in Florida. Our New Jersey offices measure approximately 1,000 square feet and are leased space.

2025 filing excerpt – Risk Factors

Our New Jersey offices measure approximately 1,000 square feet and are leased space. Our Florida offices consist of approximately 30,416 square feet of leased administrative and warehouse space and our Texas offices consist of approximately 5,514 square feet of leased administrative space. We also lease space in Canada and Mexico, as well as in other international locations for our operations across South America, Europe, Africa, Australia and Asia.

2026 filing excerpt – Risk Factors

Our New Jersey offices measure approximately 1,000 square feet and are leased space. Our Florida offices consist of approximately 30,416 square feet of leased administrative and warehouse space. We also lease space in Canada and Mexico, as well as in other international locations for our operations across South America, Europe, Africa, Australia and Asia.

2025 filing excerpt – MD&A

Management’s Discussion and Analysis of Financial Condition and Results of Operations The following discussion is intended to assist you in understanding our financial condition and results of operations and should be read in conjunction with the financial statements and related notes included elsewhere in this Form 10-K. Many of the amounts and percentages in this section have been rounded for convenience of presentation, but actual recorded amounts have been used in computations.

2026 filing excerpt – MD&A

Accordingly, some information may appear not to be computed accurately. This section of this Form 10-K discusses our financial condition and results of operations for the fiscal years ended March 31, 2026 and 2025, and year-to-year comparisons between fiscal years 2026 and 2025 in accordance with GAAP. Overview We are a global provider of AIoT solutions providing valuable connected business intelligence for managing high-value enterprise and mid-market assets that improve operational efficiencies.

Greenwave Technology Solutions, Inc.

Rank5
Lowest similarity sectionBusiness
Assessmentmedium
SEC filings2026 10-K HTML/iXBRL (SEC page, raw text) | 2025 10-K HTML/iXBRL (SEC page, raw text)

Greenwave made its business pivot more explicit by stating it sold its remaining social media assets and shut down that legacy operation. It also added a new growth objective: opening a facility with rail or deep-water port access to expand sales channels and improve profitability in scrap metal recycling. On the risk side, the company now says it regained Nasdaq compliance after the 2025 reverse split, but future compliance could be harder under tighter exchange rules.

Main Changes

  • The company added that it "sold all of our social media assets on October 28, 2021 for cash consideration equal to $10,000" and has "discontinued all operations related to our social media business," making the exit from the legacy business explicit.
  • Greenwave inserted a new strategic priority: it wants to open a facility with "rail or deep-water port access" to move scrap more efficiently to domestic steel mills and overseas foundries, and says this could increase revenue and profitability.
  • The operations description was tightened from operating two shredders to saying it operates "an automotive shredder" in Kelford and "a second automotive shredder" in Carrollton, while employee count was updated from 180 to 172.
  • The risk section now says Nasdaq compliance was regained after the 2025 reverse split, but adds that future reverse splits may not work under amended Nasdaq rules and could trigger immediate delisting if the stock falls below $1 again within one year.

Watch Items

  • The port- or rail-access facility plan signals a push to broaden customer reach and improve logistics, which could lift margins if executed well.
  • The explicit exit from social media confirms the company is now fully focused on scrap metal recycling rather than any legacy platform business.
  • The new Nasdaq rule discussion raises the stakes for share-price weakness because another reverse split may no longer be a reliable fix.

Important Filing Changes

2025 filing excerpt – Business

BUSINESS Overview We were formed on April 26, 2013 as a technology platform developer under the name MassRoots, Inc. In October 2021, we changed our corporate name from “MassRoots, Inc.” to “Greenwave Technology Solutions, Inc.” On September 30, 2021, we closed our acquisition of Empire Services, Inc. (“Empire”), which operates 13 metal recycling facilities in Virginia, North Carolina, and Ohio. The acquisition was effective October 1, 2021 upon the effectiveness of the Certificate of Merger in Virginia.

2026 filing excerpt – Business

BUSINESS Overview We were formed on April 26, 2013 as a technology platform developer under the name MassRoots, Inc. In October 2021, we changed our corporate name from “MassRoots, Inc.” to “Greenwave Technology Solutions, Inc.” We sold all of our social media assets on October 28, 2021 for cash consideration equal to $10,000 and have discontinued all operations related to our social media business. On September 30, 2021, we closed our acquisition of Empire Services, Inc. (“Empire”), which operates 13 metal recycling facilities in Virginia, North Carolina, and Ohio.

2025 filing excerpt – Business

BUSINESS Overview We were formed on April 26, 2013 as a technology platform developer under the name MassRoots, Inc. In October 2021, we changed our corporate name from “MassRoots, Inc.” to “Greenwave Technology Solutions, Inc.” On September 30, 2021, we closed our acquisition of Empire Services, Inc. (“Empire”), which operates 13 metal recycling facilities in Virginia, North Carolina, and Ohio. The acquisition was effective October 1, 2021 upon the effectiveness of the Certificate of Merger in Virginia.

2026 filing excerpt – Business

In October 2021, we changed our corporate name from “MassRoots, Inc.” to “Greenwave Technology Solutions, Inc.” We sold all of our social media assets on October 28, 2021 for cash consideration equal to $10,000 and have discontinued all operations related to our social media business. On September 30, 2021, we closed our acquisition of Empire Services, Inc. (“Empire”), which operates 13 metal recycling facilities in Virginia, North Carolina, and Ohio. The acquisition was effective October 1, 2021 upon the effectiveness of the Certificate of Merger in Virginia.

2025 filing excerpt – Risk Factors

If we lose key management or significant personnel, cannot recruit qualified employees, directors, officers, or other personnel or experience increases in our compensation costs, our business may materially suffer. We are highly dependent on our management team, specifically our Chief Executive Officer and Acting Chief Financial Officer, Danny Meeks. While we have an employment agreement with Danny Meeks, such employment agreement permits Mr.

2026 filing excerpt – Risk Factors

If we lose key management or significant personnel, cannot recruit qualified employees, directors, officers, or other personnel or experience increases in our compensation costs, our business may materially suffer. We are highly dependent on our management team, specifically our Chief Executive Officer, Danny Meeks. While we have an employment agreement with Danny Meeks, such employment agreement permits Mr.

Alternus Clean Energy, Inc.

Rank6
Lowest similarity sectionRisk Factors
Assessmentmedium
SEC filings2026 10-K HTML/iXBRL (SEC page, raw text) | 2025 10-K HTML/iXBRL (SEC page, raw text)

Alternus has sharpened its story from a broad renewable energy developer into a more focused onsite energy and microgrid platform. The new language leans heavily on EverOn and demand from AI-related infrastructure, while the risk disclosures show more explicit legal and payment problems that are already hitting the balance sheet. The filing reads like a company trying to reposition for growth while still dealing with significant creditor pressure.

Main Changes

  • The business description was rewritten from a broad "comprehensive clean energy provider" with utility-scale solar, storage, and microgrids to a "specialized energy transition platform" focused on decentralized onsite energy solutions.
  • The new filing adds a clear near-term emphasis on the microgrid and onsite energy market, citing demand from AI infrastructure, data centers, and onshored manufacturing as the main growth drivers.
  • A new joint venture, EverOn Energy LLC with Hover Energy, is highlighted as the primary route to market for wind-powered microgrids in the U.S. and U.K., replacing the prior emphasis on a broader project pipeline and utility-scale portfolio.
  • The risk section now reflects more concrete liquidity and legal pressure, including Sunrise’s $5.7 million arbitration award, a $358,000 CFGI default judgment, and a roughly $2.0 million SCAF liability with accrued interest and fees.

Watch Items

  • The strategic pivot toward microgrids suggests management is prioritizing faster-to-revenue, capital-light projects, which could improve execution if the JV gains traction.
  • The added legal liabilities and missed settlement payments point to ongoing balance-sheet strain and raise the risk that cash will remain tight.
  • The focus on data centers and industrial customers is attractive, but investors should watch whether the company can convert the new positioning into signed contracts and funded projects.

Important Filing Changes

2025 filing excerpt – Risk Factors

Through strategic investments, we are building a portfolio poised to lead the transition to a sustainable energy future. The Company was incorporated in Delaware on May 14, 2021, and was originally known as Clean Earth Acquisitions Corp. (“Clean Earth”). On October 12, 2022, Clean Earth entered into a Business Combination Agreement, as amended by that certain First Amendment to the Business Combination Agreement, dated as of April 12, 2023 (the “First BCA Amendment”) (as amended by the First BCA Amendment, the “Initial Business Combination Agreement”), and as amended and restated by that certain Amended and Restated Business Combination Agreement, dated as of December 22, 2023 (the “A&R BCA”) (the Initial Business Combination Agreement, as amended and restated by the A&R BCA, the “Business Combination Agreement”), by and among Clean Earth, Alternus Energy Group Plc (“AEG”), and the Sponsor.

2026 filing excerpt – Risk Factors

Risk Factors ” and elsewhere in this Annual Report on Form 10-K. Overview The Company was incorporated on May 14, 2021 under the laws of Delaware and was originally known as Clean Earth Acquisitions Corp. The Company closed a business combination on December 22, 2023 and changed its name to Alternus Clean Energy, Inc.

2025 filing excerpt – Risk Factors

In accordance with the Business Combination Agreement, Clean Earth issued 2,300,000 shares of common stock of Clean Earth, par value $0.0001 per share, to AEG, and AEG transferred to Clean Earth, and Clean Earth received from AEG, all of the issued and outstanding equity interests in the Acquired Subsidiaries (as defined in the Business Combination Agreement) (the “Equity Exchange,” and together with the other transactions contemplated by the Business Combination Agreement, the “Business Combination”). In connection with the Closing, the Company changed its name from Clean Earth Acquisition Corp. to Alternus Clean Energy, Inc. 46 The Company uses annual recurring revenues as a key metric in its financial management information and believes this method better reflects the long-term stability of operations into the future.

2026 filing excerpt – Risk Factors

Overview The Company was incorporated on May 14, 2021 under the laws of Delaware and was originally known as Clean Earth Acquisitions Corp. The Company closed a business combination on December 22, 2023 and changed its name to Alternus Clean Energy, Inc. We currently have 13 employees; 6 employees are located in Dublin, Ireland, 2 are located at the Company’s headquarters located in New York, 2 remote employees in the US and 3 are located in Europe.

2025 filing excerpt – Business

Business Each of the terms “Alternus,” the “Company,” “we,” “our,” “us,” and similar terms used herein refer collectively to Alternus Clean Energy, Inc., formerly known as Clean Earth Acquisitions Corp., and where appropriate, our wholly owned subsidiaries. The Company The Company was incorporated on May 14, 2021 under the laws of Delaware and currently has 14 employees; 7 employees are located Dublin, Ireland, 2 are located at the Company’s headquarters located in New York, 2 remote employees in the US and 3 are located in Europe.

2026 filing excerpt – Business

Business Each of the terms “ Alternus, ” the “ Company, ” “ we, ” “ our, ” “ us, ” and similar terms used herein refer collectively to Alternus Clean Energy, Inc. and where appropriate, our subsidiaries. The Company The Company was incorporated on May 14, 2021 under the laws of Delaware and was originally known as Clean Earth Acquisitions Corp.

Credo Technology Group Holding Ltd

Rank7
Lowest similarity sectionBusiness
Assessmentmedium
SEC filings2026 10-K HTML/iXBRL (SEC page, raw text) | 2025 10-K HTML/iXBRL (SEC page, raw text)

Credo’s new 10-K adds more explicit macro and geopolitical risk language, including inflation, higher rates, recession risk, financial institution instability, and the Israel and Middle East conflict. The core business description is otherwise steady, but management is signaling greater sensitivity to the broader operating backdrop and customer demand environment.

Main Changes

  • The forward-looking risk list now explicitly adds exposure to "economic slowdowns, inflation, stagflation, high or rising interest rates, financial institution instability, and recessions."
  • Credo also newly calls out "risks related to global economic conditions such as the current armed conflict in Israel and the Middle East," which was not listed in the prior filing.
  • The business section still emphasizes international operations, export controls, sanctions, and trade rules, but the new wording broadens the macro backdrop around demand and execution risk.

Watch Items

  • The added macro language signals management sees a tougher demand and operating environment, which could pressure customer spending and timing of design wins.
  • Explicit mention of the Israel and Middle East conflict suggests geopolitical risk is now viewed as a live business variable, not just generic boilerplate.
  • The company is still framing itself as globally exposed, so trade restrictions or regional instability could affect product shipments and customer access.

Important Filing Changes

2025 filing excerpt – Business

Business Company Overview At Credo, our mission is to redefine high-speed connectivity by delivering breakthrough solutions that enable the next generation of AI-driven applications. We are committed to enabling faster, more reliable, more energy-efficient, and scalable solutions that support the ever-expanding demands of AI, cloud computing and hyperscale networks.

2026 filing excerpt – Business

Business Company Overview At Credo, our mission is to transform connectivity at scale through fast, reliable and energy-efficient system solutions. The Company’s highspeed copper and optical interconnect products deliver industry-leading power and performance at up to 1.6T to meet the ever-expanding data infrastructure demands of AI.

2025 filing excerpt – Business

Best-in-Class Technology: We believe we are at the forefront of the high-performance connectivity market. Our architectural approach enables us to design in mature fabrication processes still deliver leading edge performance and power at a significantly lower cost. Our optimized SerDes architectures achieve industry-leading power efficiency on small die areas in cost-effective mature processes.

2026 filing excerpt – Business

Business Company Overview At Credo, our mission is to transform connectivity at scale through fast, reliable and energy-efficient system solutions. The Company’s highspeed copper and optical interconnect products deliver industry-leading power and performance at up to 1.6T to meet the ever-expanding data infrastructure demands of AI. The Company’s product portfolio includes ZeroFlap (ZF) Active Electrical Cables (AECs) and ZF optical transceivers, OmniConnect memory solutions and a suite of retimers and DSPs for optical and copper Ethernet and PCIe, all leveraging the Company’s PILOT diagnostic and analytics software platform.

2025 filing excerpt – Risk Factors

The loss of, or a significant reduction in sales to, one or more of our major customers could negatively impact our revenue and operating results. In fiscal 2025, we had one customer that accounted for 10% or more of our total revenue (such one customer accounting for 67% of total fiscal 2025 revenue). In addition, in fiscal 2025, sales to our top 10 customers accounted for approximately 90% of our total revenue.

2026 filing excerpt – Risk Factors

The loss of, or a significant reduction in sales to, one or more of our major customers could negatively impact our revenue and operating results. In fiscal 2026, we had two customers that accounted for 10% or more of our total revenue. In addition, in fiscal 2026, sales to our top 10 customers accounted for approximately 90% of our total revenue.

Why SEC Filing Changes Matter

Research by Cohen et al. (Lazy Prices, 2020) — using the complete history of SEC filings from 1995 to 2014 — shows that when firms make active changes to their annual disclosures, those changes convey an important signal about future operations and returns. A portfolio that shorted "changers" and bought "non-changers" earned over 22% per year in annual alpha historically. Changes to the Risk Factors section, Business description, and language referring to the executive team were especially informative. Critically, these returns accrued gradually as information was later revealed through news and earnings — not at the time of filing — suggesting many investors remain inattentive to these simple, public signals. This snapshot is a starting point for deeper investigation, not a buy or sell recommendation.

For more like this, see the full SEC What Changed archive, browse more equity research reports, or subscribe to Quantitative Research Notes for new filing-change alerts as soon as they publish.

Research disclaimer

This material is provided for research and educational purposes only. It is not investment advice, a recommendation, or an offer to buy or sell any security or strategy.

Receive research notes

Get concise market research, backtests, and risk notes when new work is published.





Double opt-in. No personalized investment advice.

Leave a Reply

Your email address will not be published. Required fields are marked *